New England Research & Management’s Express Scripts Holding Company ESRX Stock Holding History

New England Research & Management’s Portfolio ESRX Stock Details ESRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,450	Closed	-$262K	–	182
2016 Q2	$262K	Sell	3,450 -100	-3%	-$7.35K	0.23%	137
2016 Q1	$244K	Buy	3,550 +300	+9%	+$21.6K	0.21%	140
2015 Q4	$284K	Sell	3,250 -1,100	-25%	-$94.2K	0.25%	131
2015 Q3	$352K	Buy	4,350 +300	+7%	+$26.1K	0.34%	111
2015 Q2	$360K	Sell	4,050 -100	-2%	-$8.74K	0.3%	120
2015 Q1	$360K	Buy	+4,150	New	+$348K	0.31%	119

Other funds holding ESRX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

New England Research & Management's ESRX Position: Q3 2016 in Review

New England Research & Management sold out of Express Scripts Holding Company (ESRX) in Q3 2016, closing a stake of 3,450 shares — an estimated $262K sold.

New England Research & Management first reported a position in ESRX in Q1 2015 and held it in 6 quarters. The position peaked at $360K in Q2 2015. 1,150 funds tracked by Wall St. Rank hold ESRX as of Q3 2016.

New England Research & Management reported no remaining Express Scripts Holding Company position as of Q3 2016 after selling out during the quarter.
New England Research & Management sold 3,450 Express Scripts Holding Company shares in Q3 2016, an estimated $262K.
New England Research & Management first reported a position in Express Scripts Holding Company in Q1 2015 and held it in 6 quarters.
New England Research & Management's Express Scripts Holding Company position peaked at $360K in Q2 2015.
1,150 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q3 2016.

Based on New England Research & Management's 13F filing for Q3 2016, filed 5 Oct 2016.